Pharmacology Review CME Package: $399.99
Access Duration: 30 Months
Deliverables: 12 AAPA Category 1 Pharmacology Credits, 120+ Clinical Questions
CME Add-ons: $100 – $1500 Amazon or Apple Gift Cards
Physician Assistants (PAs) face a complex regulatory environment when maintaining national certification and state licensure. While the NCCPA manages the broader requirements for Category 1 and Category 2 CME, individual state medical boards often impose specific mandates for pharmacology and prescribing credits. Failure to accurately track and report these hours can lead to registration delays, licensure issues, or NCCPA audit failures.
Below are seven common mistakes PAs make with their pharmacology credits and the clinical steps necessary to correct them.
1. Misinterpreting Accreditation Statements
A common error is assuming any "pharmacology talk" automatically qualifies for AAPA Category 1 credit. Many industry-sponsored lectures or pharmaceutical dinners provide educational value but do not possess the necessary accreditation. To count as Category 1, the activity must be designated as such by an approved body, such as the AAPA or an ACCME-accredited organization (AMA PRA Category 1 Credit™), which the AAPA accepts for PAs.
The Fix: Always verify the accreditation statement before participating. It must specifically state, "This activity is designated for X AAPA Category 1 CME credits." If this language is absent, the activity must be logged as Category 2.
2. Failing to Distinguish Between Pharmacology and Prescribing Hours
Many state boards distinguish between general "pharmacology" and specific "prescribing" or "controlled substance" hours. For example, some states require two hours of opioid-specific education as part of your total pharmacology requirement. PAs often log general pharmacology credits and assume they meet these niche state mandates.
The Fix: Cross-reference your state medical board’s specific requirements. Use a dedicated pharmacology review, like the Pharmacology Review CME, to ensure you have a robust foundation of credits that can be categorized appropriately during licensure renewal.
3. Over-claiming Credits for Partial Participation
The AAPA and NCCPA are explicit: PAs should only claim credit commensurate with the extent of their participation in an activity. If a pharmacology course offers 12 credits but you only completed six hours of the material, claiming the full 12 is a violation of professional standards and an audit risk.
The Fix: Track your actual time spent on modules. For our pharmacology package, the 120+ questions and review content are designed to provide 12 hours of rigorous education. Ensure you complete the entire curriculum before claiming the full credit amount.
4. Missing the 1.5x Self-Assessment Bonus
Many PAs overlook the NCCPA "bonus" for Self-Assessment (SA) activities. While the Pharmacology course provides 12 hours of standard Category 1 credit, our PANRE Review Course provides 100 hours of AAPA Category 1 credit. If an activity is designated as Self-Assessment, the NCCPA applies a 1.5x multiplier (e.g., 20 SA credits become 30 credits in your total).
The Fix: Incorporate Self-Assessment activities into your CME cycle to reach your 100-hour requirement faster. This is particularly efficient when preparing for the NCCPA Blueprint content areas.
5. Poor Record Keeping for NCCPA Audits
The NCCPA recommends that PAs maintain documentation of their Category 1 CME for the current and the previous two-year cycle. A frequent mistake is discarding digital certificates or relying solely on a provider's website to "host" your records. If that provider goes offline or you lose access, you are defenseless in an audit.
The Fix: Create a dedicated digital folder for each CME cycle. Store PDFs of your certificates immediately upon completion. Ensure the certificate includes your name, the provider, the date, the number of credits, and the accreditation statement.
6. Relying on Outdated Pharmacology Content
Pharmacology is one of the fastest-evolving fields in medicine. Using "leftover" review books from five years ago to meet your requirements often leads to practicing with outdated guidelines, especially in rapidly changing areas like anticoagulation, SGLT2 inhibitors, or biological therapies.
The Fix: Utilize content written by PAs for PAs. Our pharmacology review is updated to reflect current clinical practice and the NCCPA Blueprint. This ensures that while you earn your 12 Category 1 credits, you are also maintaining clinical competency.
7. Wasting Your CME Budget
Many PAs leave their employer-provided professional development funds on the table at the end of the year or spend them on low-value individual lectures. They fail to maximize the utility of these funds for their personal and professional enrichment.
The Fix: Use your CME money efficiently. We offer CME packages with Amazon and Apple Gift Card add-ons. By adding a $100 to $1,500 gift card to your purchase, you can acquire the pharmacology or PANRE review you need while also securing funds for additional educational tools, books, or technology.
Clinical Pharmacology Assessment
Test your knowledge with these clinical vignettes focused on pharmacology and patient management.
Question 1
Your patient is a 64-year-old male with a history of hypertension and heart failure with reduced ejection fraction (HFrEF). He was recently started on an ACE inhibitor. He presents today with a dry, non-productive cough that has persisted for two weeks. He denies fever, chills, or shortness of breath. His vital signs are stable, and his lungs are clear to auscultation.
Which of the following is the most appropriate next step in managing this patient’s medication?
A) Discontinue the ACE inhibitor and start a Calcium Channel Blocker
B) Discontinue the ACE inhibitor and start an Angiotensin II Receptor Blocker (ARB)
C) Add an antitussive and continue the ACE inhibitor
D) Decrease the dose of the ACE inhibitor by 50%
Correct Answer: B) Discontinue the ACE inhibitor and start an Angiotensin II Receptor Blocker (ARB)
Explanation: The patient is experiencing a classic side effect of ACE inhibitors caused by the accumulation of bradykinin. ARBs do not affect bradykinin levels and are the appropriate alternative for patients with HFrEF who cannot tolerate ACE inhibitors due to cough. Option A is incorrect because CCBs are not first-line for HFrEF management. Option C is inappropriate as the cough will likely persist as long as the ACE inhibitor is used. Option D is incorrect because the cough is not typically dose-dependent.
Question 2
Your patient is a 28-year-old female who presents with symptoms of an uncomplicated urinary tract infection (UTI), including dysuria and urinary frequency. She has a known severe allergy to sulfonamides (hives and respiratory distress).
Which of the following medications should be avoided in this patient?
A) Nitrofurantoin
B) Trimethoprim-Sulfamethoxazole
C) Fosfomycin
D) Ciprofloxacin
Correct Answer: B) Trimethoprim-Sulfamethoxazole
Explanation: Trimethoprim-Sulfamethoxazole (Bactrim) contains a sulfonamide component and must be avoided in patients with a sulfa allergy. Nitrofurantoin (A) and Fosfomycin (C) are first-line agents for uncomplicated UTIs and are safe in this patient. Ciprofloxacin (D) is a fluoroquinolone and is also an alternative, though typically reserved for more complex cases or when first-line agents cannot be used.
Question 3
Your patient is a 72-year-old male with a history of Parkinson's disease. His family reports that he has recently begun experiencing visual hallucinations and increased confusion. He is currently taking Carbidopa/Levodopa 25/100 mg three times daily. Physical examination shows no signs of acute infection or metabolic derangement.
Which of the following medications is specifically FDA-approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis?
A) Haloperidol
B) Pimavanserin
C) Risperidone
D) Clozapine
Correct Answer: B) Pimavanserin
Explanation: Pimavanserin is a selective serotonin inverse agonist specifically indicated for Parkinson's disease psychosis. It does not interfere with dopaminergic therapy, unlike typical antipsychotics like Haloperidol (A) or atypical antipsychotics like Risperidone (C), which can worsen motor symptoms. While Clozapine (D) is effective, it is often a second-line choice due to the requirement for intensive blood monitoring for agranulocytosis.
Optimize Your CME Strategy
Whether you are preparing for the PANRE or need to satisfy state pharmacology requirements, CME Review Courses provides high-yield, PA-focused content.
Available Courses:
- Pharmacology Review CME: Earn 12 AAPA Category 1 credits with over 120 practice questions. Ideal for meeting state-specific pharmacology mandates. Price: $399.99.
- PANRE Review Course: A comprehensive review offering 100 hours of AAPA Category 1 credit. Designed to cover the NCCPA Blueprint efficiently.
- CME with Gift Cards: Add an Amazon or Apple Gift Card ($100 – $1,500) to your purchase to maximize your professional development budget.
Managing your pharmacology credits doesn't have to be a source of stress. By avoiding these seven common mistakes and utilizing high-quality, accredited review materials, you can ensure your certification remains current while enhancing your clinical practice.
For more information on our packages and gift card options, visit cmereviewcourses.com.